LJM716
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for LJM716, covering 2016-04-21 to 2016-04-21. Get the full timeline:
Most recent: Clinical Trial Update: Study of Efficacy and Safety of LJM716 and Cetuximab in Head and Neck Squamous Cell Carcinoma Patients [Phase 1, Phase 2]